Application
MAP6D1 Antibody (C-term) western blot analysis in MCF-7 cell line lysates (35ug/lane).This demonstrates the MAP6D1 antibody detected the MAP6D1 protein (arrow).Application
MAP6D1 Antibody (C-term) flow cytometric analysis of MCF-7 cells (right histogram) compared to a negative control cell (left histogram).FITC-conjugated goat-anti-rabbit secondary antibodies were used for the analysis.| Product Name | MAP6D1 Antibody (C-term) |
|---|---|
| Antibody Type | Primary Antibodies |
| Antigen Alias | MAP6D1; MAP6 domain-containing protein 1; 21 kDa STOP-like protein |
| Clonality | Polyclonal |
|---|---|
| Isotype | Ig |
| Host Species | Rabbit |
| Tested Applications | WBFC |
| WB:1:100~500 FC |
|
| Species Reactivity | Human |
| Concentration | 1mg/ml |
| Alternative Names | MAP6D1 MAP6 domain-containing protein 1 21 kDa STOP-like protein |
|---|---|
| Molecular Weight(MW) | 21005 Da |
| Function | May have microtubule-stabilizing activity (By similarity) |
| Tissue Specificity | This MAP6D1 antibody is generated from rabbits immunized with a KLH conjugated synthetic peptide between 129-159 amino acids from the C-terminal region of human MAP6D1. |
| Cellular Localization | Golgi apparatus. Cytoplasm, cytoskeleton (By similarity). Note=Colocalizes with microtubules (By similarity) |
| Entrez Gene | 79929 |
|---|---|
| Nucleotide Accession | NP_079147.1 |
Application
MAP6D1 Antibody (C-term) western blot analysis in MCF-7 cell line lysates (35ug/lane).This demonstrates the MAP6D1 antibody detected the MAP6D1 protein (arrow).
Application
MAP6D1 Antibody (C-term) flow cytometric analysis of MCF-7 cells (right histogram) compared to a negative control cell (left histogram).FITC-conjugated goat-anti-rabbit secondary antibodies were used for the analysis.| Application Notes | WB:1:100~500 FC |
|---|
| Form | Liquid |
|---|---|
| Storage Instructions | For short-term storage, store at 4° C. For long-term storage, aliquot and store at -20ºC or below. Avoid multiple freeze-thaw cycles. |
| Storage Buffer | Purified polyclonal antibody supplied in PBS with 0.09% (W/V) sodium azide. This antibody is purified through a protein A column, followed by peptide affinity purification. |
